Pulmonary blisters can be divided into three types. type I: Pulmonary blisters with essentially normal lung parenchyma, often solitary, with a narrow base, usually located in the apical lung, often accompanied by apical scar traction emphysema, with a clear border between the blister and the lung parenchyma, and normal tissue structure of the basal lung parenchyma except for pressure dysplasia. Unless the pulmonary blister is particularly large or spontaneous pneumothorax or other complications occur, there are often no clinical symptoms. Pulmonary impairment is manifested by restrictive respiratory dysfunction without COPD manifestations. The indications for surgery in this type are: (1) Pulmonary blister occupying more than 1/3 of the volume of one side of the chest cavity. (2) Complicated spontaneous pneumothorax. (3) Secondary infection of the blister, hemoptysis, chest pain, and worsening dyspnea. The best surgical option for this type should be pulmonary herpetomy. type II: pulmonary herpes with emphysema, commonly found on the diaphragmatic surface of the upper and anterior middle lobes and lower lobes, with emphysematous lung tissue and large air spaces at the base of the herpes and the alveolar wall mainly being the pleura. Pulmonary macules are formed as a result of severe panlobular emphysema damaging the surface of the lung parenchyma. The clinical symptoms are related to the volume of the pulmonary blister, the degree of pressure on the surrounding lung parenchyma, and the severity of the emphysematous lesion of the lung parenchyma, mainly manifesting as emphysematous symptoms and less severe infection symptoms. Type III: Destructive pulmonary blister: The pulmonary blister is diffusely distributed throughout or in a large part of the lung parenchyma, and the lung parenchyma has been exhausted by emphysema, pulmonary blister rupture, and often extends to the hilum. X-rays, chest CT, blood gas analysis, pulmonary function, and pulmonary ventilation and perfusion scans can assist in staging and provide the basis for treatment planning. More than 90% of the pulmonary herpes resections performed in our department are done under minimally invasive thoracoscopic surgery, which has the advantage of being less invasive, and the patient’s hospital stay is significantly shorter, with an average of 3-4 days after surgery.